Thanks for your interest Emmjay.Firstly let me say,I'm not critical of D.R. & the board in any way other than the financials & their timing.The product is probably the best of it's type &being such,a dream to promote.D.R. Failed to address the burn rate of capital, estimated IMO at 1.3 to 1.5 mill.Don't be conned by the people suggesting that trading approval is close,it's not. If they pass the feasibility trials they face 6 months wait for approval to move onto the pivotal trials.This alone can chew up 9mlll.Even with what has been raised they will not see the distance IMO. add to this that 21 of 32 resolutions referring to remuneration & share bonuses are presented for shareholders approval I find appalling. The timing of both the listing &capital raising was poor & will prove costly.Earnest & young's opinion that they doubt it will survive is sad & failed to be addressed by DR.I was caught badly in Ventracore ,a,very similar case.Hope this helps. Cheers.
SHC Price at posting:
3.7¢ Sentiment: ST Sell Disclosure: Held
